Abacus Life (NASDAQ:ABL - Get Free Report) is expected to be posting its Q2 2025 quarterly earnings results after the market closes on Thursday, August 7th. Analysts expect Abacus Life to post earnings of $0.17 per share and revenue of $43.38 million for the quarter.
Abacus Life (NASDAQ:ABL - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.16 by $0.02. Abacus Life had a negative net margin of 13.35% and a positive return on equity of 16.76%. The company had revenue of $44.14 million during the quarter, compared to analysts' expectations of $39.51 million. On average, analysts expect Abacus Life to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Abacus Life Stock Performance
Abacus Life stock traded down $0.12 during midday trading on Friday, hitting $5.29. The company's stock had a trading volume of 799,119 shares, compared to its average volume of 606,371. Abacus Life has a 1-year low of $4.60 and a 1-year high of $11.86. The company has a debt-to-equity ratio of 0.55, a current ratio of 0.47 and a quick ratio of 0.47. The company has a 50-day moving average price of $5.77 and a two-hundred day moving average price of $7.10. The company has a market cap of $512.34 million, a price-to-earnings ratio of -23.00 and a beta of 0.01.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Abacus Life stock. Bison Wealth LLC boosted its holdings in shares of Abacus Life, Inc. (NASDAQ:ABL - Free Report) by 492.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 61,125 shares of the company's stock after buying an additional 50,800 shares during the period. Bison Wealth LLC owned approximately 0.06% of Abacus Life worth $479,000 as of its most recent SEC filing.
Wall Street Analyst Weigh In
Several analysts have weighed in on the stock. Piper Sandler dropped their price objective on shares of Abacus Life from $12.00 to $10.00 and set an "overweight" rating for the company in a research note on Wednesday, July 2nd. Maxim Group initiated coverage on shares of Abacus Life in a research report on Tuesday, April 29th. They issued a "buy" rating and a $14.00 target price for the company. Six research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $13.75.
Get Our Latest Research Report on ABL
About Abacus Life
(
Get Free Report)
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
See Also
Before you consider Abacus Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Abacus Life wasn't on the list.
While Abacus Life currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access